Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00718
|
|||||
| Drug Name |
Tubercidin
|
|||||
| Synonyms |
Sparsamycin A
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C11H14N4O4
|
|||||
| Canonical SMILES |
C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CO)O)O
|
|||||
| InChI |
InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1
|
|||||
| InChIKey |
HDZZVAMISRMYHH-KCGFPETGSA-N
|
|||||
| CAS Number |
CAS 69-33-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 266.25 | Topological Polar Surface Area | 127 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
-1.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103171721
, 103914905
, 104311514
, 117356057
, 124812646
, 128047323
, 134971531
, 134978868
, 137248889
, 143236531
, 144187478
, 14872494
, 152146259
, 152198607
, 162202461
, 162250667
, 178101465
, 179561976
, 182462121
, 198982412
, 223702430
, 226399501
, 241383350
, 24899902
, 249864885
, 252072294
, 252212958
, 252403405
, 26757019
, 29225241
, 46392900
, 46530721
, 47193881
, 50040490
, 50506281
, 57323288
, 621129
, 7890700
, 7980854
, 8153925
, 92474076
, 93166873
|
|||||
| ChEBI ID |
CHEBI:48267
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ENT3 | Transporter Info | Equilibrative nucleoside transporter 3 | Substrate | [1] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | ENT3 | Transporter Info | Km = 1860 microM | Xenopus Oocytes-ENT3 | [1] | |
| References | ||||||
| 1 | Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem. 2005 Apr 22;280(16):15880-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.